查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650730

全球神經調節市場

Neuromodulation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 298 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球神經調節市場規模將達到 123 億美元

2024 年全球神經調節市場規模估計為 72 億美元，預計 2030 年將達到 123 億美元，2024 年至 2030 年的複合年成長率為 9.2%。脊髓刺激是報告中分析的一個領域，預計到分析期結束時複合年成長率為 9.2%，達到 54 億美元。在分析期內，深部腦部刺激部分預計將以 9.6% 的複合年成長率成長。

美國市場規模估計為 33 億美元，中國市場預估年複合成長率為 10.9%

預計 2024 年美國神經調節市場價值將達 33 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 8.985 億美元，2024-2030 年分析期間的複合年成長率為 10.9%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 8.8% 和 9.4%。在歐洲，預計德國的複合年成長率約為 8.5%。

全球神經調節市場趨勢與促進因素摘要

神經調節是醫學領域的一個前沿領域，專注於透過將電或藥物直接輸送到身體的特定部位來改變神經活動。透過改變神經系統內的活動，該技術被用於各種治療環境中，治療慢性疼痛、神經系統疾病和精神疾病。神經調節包括幾種技術，包括脊髓刺激、深部腦部刺激、迷走神經刺激和經顱磁刺激，每種技術都針對特定的疾病進行治療，如帕金森氏症、癲癇、憂鬱症和慢性疼痛綜合症。透過精確控制神經活動，這些治療方法比傳統治療方法具有顯著優勢，通常可減少副作用並改善患者預後。

過去幾十年來，神經調節背後的技術得到了迅速發展。早期的神經調節設備體積龐大且功能有限。然而，生物醫學工程的進步促進了更緊湊、更光滑、更有效率的設備的開發。現代神經調節系統通常配備無線連接、可充電電池和高級編程功能等功能，可根據患者的即時回饋調整個人化治療方法。此外，機器學習和人工智慧的整合正在提高這些治療的準確性和有效性，為更具適應性和反應性的治療方案鋪平了道路。透過臨床試驗和持續的研究，神經調節的潛在應用範圍不斷擴大，進一步擴大了其功效。

神經調節市場的成長受到多種因素的推動。首先，慢性疼痛、憂鬱症和神經病變等慢性和衰弱性疾病的發生率日益上升，推動了對更有效治療方案的需求。此外，全球老齡化人口的不斷增加以及人們對神經刺激設備的功效和安全性的認知不斷提高也推動了市場的發展。其次，技術進步顯著提高了神經調節療法的有效性、安全性和患者的接受度。微創手術技術以及更小、更耐用設備的開發等技術創新使這些治療更容易獲得，對更多患者更有吸引力。第三，越來越多的臨床證據支持神經調節在改善患者預後的功效，正在獲得醫療保健提供者和保險公司的認可，從而進一步推動市場成長。最後，世界人口老化導致神經系統疾病和慢性疼痛的增加，擴大了神經調節治療的潛在患者群體。這些因素加上持續的研究和開發努力，支撐了神經調節市場的強勁和動態特性。

部分

技術（脊髓刺激、深部腦部刺激、薦椎神經刺激神經刺激、經皮電神經刺激、重複經顱磁刺激、其他技術）、應用（慢性疼痛、腰背症候群、憂鬱症、癲癇、巴金森氏症、偏頭痛、其他應用）

受訪企業範例（共83家）

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • Bioness Inc.
  • Beijing Pins Medical Co., Ltd.
  • Axonics Modulation Technologies, Inc.
  • Biegler GmbH
  • Cirtec Medical Corporation
  • Cala Health
  • BioControl Medical Ltd.
  • Atlantic Therapeutics Group Limited
  • Bio-Medical Research Limited
  • Capitol Pain Institute
  • Autonomix Medical
  • Bioinduction

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 全球市場概覽
  • 世界品牌
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13576

Global Neuromodulation Market to Reach US$12.3 Billion by 2030

The global market for Neuromodulation estimated at US$7.2 Billion in the year 2024, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Deep Brain Stimulation segment is estimated at 9.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 10.9% CAGR

The Neuromodulation market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$898.5 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 9.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Global Neuromodulation Market - Key Trends & Drivers Summarized

Neuromodulation is a cutting-edge field within medical science that focuses on altering nerve activity through targeted delivery of electrical or pharmaceutical agents directly to a specific area of the body. This technique is employed in a variety of therapeutic contexts, addressing chronic pain, neurological disorders, and psychiatric conditions by modifying the activity within the nervous system. Neuromodulation encompasses several methods, including spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation, each tailored to treat specific ailments such as Parkinson's disease, epilepsy, depression, and chronic pain syndromes. By precisely controlling neural activity, these therapies offer significant benefits over traditional treatments, often resulting in improved patient outcomes with fewer side effects.

The technology behind neuromodulation has rapidly evolved over the past few decades. Early iterations of neuromodulation devices were bulky and limited in their capabilities. However, advancements in biomedical engineering have led to the development of more compact, sophisticated, and efficient devices. Modern neuromodulation systems often include features such as wireless connectivity, rechargeable batteries, and advanced programming capabilities, allowing for personalized treatment regimens that can be adjusted based on real-time feedback from the patient. Additionally, the integration of machine learning and artificial intelligence is enhancing the precision and effectiveness of these therapies, paving the way for more adaptive and responsive treatment options. Clinical trials and ongoing research are continually expanding the potential applications of neuromodulation, demonstrating its efficacy in treating an ever-growing list of conditions.

The growth in the neuromodulation market is driven by several factors. Firstly, the increasing prevalence of chronic and debilitating conditions such as chronic pain, depression, and neurological disorders has heightened the demand for more effective treatment options. Furthermore, increasing aging population globally, and growing awareness of the efficacy and safety of neurostimulator devices are aiding the market. Secondly, technological advancements have significantly improved the efficacy, safety, and patient acceptance of neuromodulation therapies. Innovations such as minimally invasive surgical techniques and the development of smaller, more durable devices have made these treatments more accessible and appealing to a broader patient population. Thirdly, the growing body of clinical evidence supporting the effectiveness of neuromodulation in improving patient outcomes is fostering greater acceptance among healthcare providers and insurers, further propelling market growth. Lastly, an aging global population is contributing to an increased incidence of neurological and chronic pain conditions, thus expanding the potential patient base for neuromodulation therapies. These factors, combined with continuous research and development efforts, underscore the robust and dynamic nature of the neuromodulation market.

SCOPE OF STUDY:

The report analyzes the Neuromodulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Other Technologies); Application (Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 83 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • Bioness Inc.
  • Beijing Pins Medical Co., Ltd.
  • Axonics Modulation Technologies, Inc.
  • Biegler GmbH
  • Cirtec Medical Corporation
  • Cala Health
  • BioControl Medical Ltd.
  • Atlantic Therapeutics Group Limited
  • Bio-Medical Research Limited
  • Capitol Pain Institute
  • Autonomix Medical
  • Bioinduction

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Neuromodulation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Neurological Disorders
    • A Prelude to Neuromodulation
    • Indications for Neuromodulation Therapy
  • GLOBAL MARKET OVERVIEW
    • Neuromodulation Market Set for a Robust Growth
    • Neuromodulation Market by Segment
    • Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS) Represents the Largest Segments
    • Neuromodulation Devices by Technology
    • Neuromodulation Market by Application
    • Growing Clinical Applications to Drive Demand
    • US and Europe Dominate the Market
    • Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
    • Competition
    • Select FDA Approved Neuromodulation Devices in Recent Years
    • Recent Market Activity
    • Market Restraints and Challenges
  • WORLD BRANDS
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Incidence of Neurological Disorders: A Key Market Driver
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • Recent Developments in Spinal Cord Injury Treatment
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
    • Neuromodulation Technologies to Gain Preference Over Opioids
    • Tibial Neuromodulation to Impact Overactive Bladder Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Transcutaneous Electrical Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Repetitive Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 43: World Neuromodulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neuromodulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of World 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of World Recent Past, Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of World Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of World 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson's Disease, Migraine and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION